Andrea Asensio-Grau
Overview
Explore the profile of Andrea Asensio-Grau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez-Gomez E, Asensio-Grau A, Heredia A, Garcia-Hernandez J, Calvo-Lerma J, Andres A
Food Funct
. 2024 Dec;
16(2):570-582.
PMID: 39703012
In view of the increasing demand for plant-based protein alternatives, along with the increased protein requirements of older adults, the formulation of new food concepts based on protein-rich ingredients from...
2.
Asensio-Grau A, Garriga M, Vicente S, Andres A, Ribes-Koninckx C, Calvo-Lerma J
Nutrients
. 2024 Dec;
16(23.
PMID: 39683464
Background/objectives: Early life gut microbiota plays a pivotal role in shaping immunity, metabolism, and overall health outcomes. This is relevant in healthy infants but may be even more crucial in...
3.
Viteri-Echeverria J, Andres A, Calvo-Lerma J, Heredia A, Garcia-Hernandez J, Asensio-Grau A
Food Funct
. 2024 May;
15(12):6512-6522.
PMID: 38804915
Children with Cystic Fibrosis (CF) are more likely to have intestinal dysbiosis due to recurrent antibiotic therapy and the conventional hypercaloric diet administered to them. This study aimed at evaluating...
4.
Asensio-Grau A, Ferriz-Jordan M, Hervas D, Heredia A, Garcia-Hernandez J, Garriga M, et al.
Pediatr Res
. 2024 May;
96(7):1794-1802.
PMID: 38778229
Background: Fat malabsorption in children with cystic fibrosis (CF) leads to poor nutritional status and altered colonic microbiota. This study aimed at establishing the faecal lipid profile in children with...
5.
Viteri-Echeverria J, Calvo-Lerma J, Ferriz-Jordan M, Garriga M, Garcia-Hernandez J, Heredia A, et al.
Nutrients
. 2023 Dec;
15(24).
PMID: 38140272
A "high-fat, high-energy diet" is commonly recommended for children with cystic fibrosis (CF), leading to negative consequences on dietary patterns that could contribute to altered colonic microbiota. The aim of...
6.
Asensio-Grau A, Heredia A, Garcia-Hernandez J, Cabrera-Rubio R, Masip E, Ribes-Koninckx C, et al.
Pediatr Res
. 2023 Dec;
95(6):1519-1527.
PMID: 38092964
Background: Children with cystic fibrosis (CF) present with gut dysbiosis, and current evidence impedes robust recommendations on the use of prebiotics. This study aimed at establishing the prebiotic potential of...
7.
Asensio-Grau A, Calvo-Lerma J, Ferriz-Jordan M, Garcia-Hernandez J, Heredia A, Andres A
Nutrients
. 2023 Sep;
15(17).
PMID: 37686878
Cystic Fibrosis-related gut dysbiosis (CFRGD) has become a recognised complication in children with this condition, and current evidence remains insufficient to guide the selection of probiotic strains for supplementation treatments....
8.
Calvo-Lerma J, Asensio-Grau A, Garcia-Hernandez J, Heredia A, Andres A
Foods
. 2022 Feb;
11(3).
PMID: 35159560
Fermentation of plant-based substrates with edible fungi enhances the nutrient profile and digestibility, but it has been scarcely applied to edible seeds, which are rich in healthy lipids. In this...
9.
Calvo-Lerma J, Boon M, Colombo C, De Koning B, Asseiceira I, Garriga M, et al.
J Cyst Fibros
. 2020 Dec;
20(5):e33-e39.
PMID: 33279468
Background: Patients with cystic fibrosis (CF) and pancreatic insufficiency need pancreatic enzyme replacement therapy (PERT) for dietary lipids digestion. There is limited evidence for recommending the adequate PERT dose for...
10.
Asensio-Grau A, Calvo-Lerma J, Heredia A, Andres A
Food Chem
. 2020 Oct;
342:128387.
PMID: 33097324
Salmon is the main dietary source of omega-3 lipids and contains high-biological value protein. However, processing techniques could affect macronutrient digestibility. Also, altered intestinal conditions, particularly given in pancreatic insufficiency,...